I7W-MC-UDAA - ClinicalTrials.gov - NCT04342897
I7W-MC-UDAA - ClinicalTrials.gov - NCT04342897
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must be admitted to the hospital for less than 48 hours with respiratory involvement
Participants must have confirmed pneumonia
Participants must have presumed or confirmed COVID-19
Participants must NOT
Participants must not have Acute Respiratory Distress Syndrome (ARDS) or require immediate ventilation, or be ineligible for ventilation
Participants must not have any serious medical condition or medication that prevents participation
Participants must not be at the point of death
Participants must not have had recent major surgery
Participants must not have had recent blood clots or events like heart attack
Participants must not have congestive heart failure or irregular heartbeat
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3127804, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
210
Trial Dates
April 2020 - October 2020
Trial Phase
2
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must be admitted to the hospital for less than 48 hours with respiratory involvement
Participants must have confirmed pneumonia
Participants must have presumed or confirmed COVID-19
Participants must NOT
Participants must not have Acute Respiratory Distress Syndrome (ARDS) or require immediate ventilation, or be ineligible for ventilation
Participants must not have any serious medical condition or medication that prevents participation
Participants must not be at the point of death
Participants must not have had recent major surgery
Participants must not have had recent blood clots or events like heart attack
Participants must not have congestive heart failure or irregular heartbeat
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3127804, Placebo
Could I receive a Placebo?
yes
Enrollment Goal
210
Trial Dates
April 2020 - October 2020
Trial Phase
2
Trial Locations
Hide locations not currently recruiting